- Role
- Country
- Date of registration
- Address
NL-MF-000000423HD601216760001Cavex Avalloy capsule II spill 300 caps is an MDD-legacy medical device registered in EUDAMED. It is classified as Class IIa. Manufactured by Cavex Holland BV. Placed on the EU market in Netherlands. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on May 18, 2026
B-E241LM0320Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
E241LM0320
DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA support is coming.
8 warnings recorded — scroll inside the panel to see all entries.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Contains latex
A "contains latex" flag warns that a device contains natural rubber latex, which can trigger allergic reactions in sensitive patients.
CMR substance
A CMR flag warns that a device contains a substance that is carcinogenic, mutagenic or toxic to reproduction above a defined threshold.
Endocrine-disrupting substance
An endocrine-disruptor flag warns that a device contains a substance with endocrine-disrupting properties above a defined threshold.
Primary placement in Netherlands; available across 15 countries total.
| Country | On market since | Until |
|---|---|---|
| NetherlandsPrimary placement | — | Jun 30, 2026 |
| Belgium | — | Jun 30, 2026 |
| Bulgaria | — | Jun 30, 2026 |
| Cyprus | — | Jun 30, 2026 |
| Czechia | — | Jun 30, 2026 |
| Germany | — | Jun 30, 2026 |
| EL | — | Jun 30, 2026 |
| Spain | — | Jun 30, 2026 |
| France | — | Jun 30, 2026 |
| Croatia | — | Jun 30, 2026 |
| Hungary | — | Jun 30, 2026 |
| Lithuania | — | Jun 30, 2026 |
| Slovenia | — | Jun 30, 2026 |
| Slovakia | — | Jun 30, 2026 |
| Türkiye | — | Jun 30, 2026 |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
E241LM0320Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
B-E241LM0320LM032UDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
MDR risk classes
MDR risk classes rank medical devices from lowest risk (Class I) to highest (Class III), which determines how much regulatory scrutiny they face.
European Medical Device Nomenclature — the EU product classification assigned to this device.
Q01010101AMALGAMS FOR RESTORATIVE DENTISTRY++E241AA000LXOn the marketCavex Avalloy capsule I spill 300 capsB-E241LM0310On the marketCavex Avalloy capsule I spill 50 capsB-E241LM0210On the marketCavex Avalloy capsule II spill 50 capsB-E241LM0220On the marketCavex Avalloy capsule III spill 300 capsB-E241LM0330On the marketCavex Avalloy capsule III spill 50 capsB-E241LM0230On the marketNo certificate specifically references this device's Basic UDI-DI.
Certificate health across this manufacturer's portfolio.
HZ 1710455-1IssuedNotified body
A notified body is an independent organisation, designated by an EU country, that audits manufacturers and certifies higher-risk devices before they can be CE-marked.
View in glossary →